Baclofen Withdrawal – REBEL EM

Baclofen Withdrawal – REBEL EM

Medical CategoriesAbdominal and GastroinstestinalAllergy and ImmunologyCardiovascularDermatologyEMS and DisasterEndocrine, Metabolic, Fluid, and ElectrolytesEnvironmentalEthical and LegalHead, Eye, Ear, Nose, and ThroatHematology and OncologyInfectious DiseaseNeurologyObstetrics and GynecologyOrthopedicsPediatricsProcedures and SkillsPyschobehavioralRenal and GenitourinaryResuscitationThoracic and RespiratoryToxicologyTrauma Source link

Read More
Mythbuster: Administration of Vasopressors Through Peripheral Intravenous Access – REBEL EM

Mythbuster: Administration of Vasopressors Through Peripheral Intravenous Access – REBEL EM

Background: Vasopressors are frequently used in critically ill patients with hemodynamic instability both in the emergency department (ED) as well as intensive care units (ICUs). Typically, vasopressors are given through central venous catheters (CVCs) as opposed to peripheral intravenous (PIV) access due to the concerns about adverse events (i.e. tissue ischemia/necrosis) associated with extravasation through…

Read More
Double Sequential (or Simultaneous?) Defibrillation for Refractory VF

Double Sequential (or Simultaneous?) Defibrillation for Refractory VF

The presence of sudden cardiac death is estimated to occur 300,000 to 350,000 annually with over 90% of such deaths as a results of ventricular fibrillation (VF). ACLS guidelines dictate that after addressing reversible causes or factors leading to the arrhythmia (hypoxia, electrolyte disturbances, mechanical factors, volume depletion), defibrillation should be performed with 360 J…

Read More